NasdaqCM - Delayed Quote USD
Lexaria Bioscience Corp. (LEXX)
1.6900
+0.1000
+(6.29%)
At close: 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.37M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BUNKA CHRISTOPHER ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 7, 2025 |
| CHRISTOPHER RICHARD C Chief Executive Officer | Purchase at price 2.24 - 2.47 per share. | Direct | 118,392 | Dec 3, 2024 |
| TURKEL CATHERINE C Director | Purchase at price 3.13 per share. | Direct | 5,008 | Aug 12, 2024 |
| CARLE VANESSA Officer | Sale at price 4.00 per share. | Direct | 10,268 | Jul 31, 2024 |
| CARLE VANESSA Officer | Conversion of Exercise of derivative security at price 1.15 per share. | Direct | 2,875 | May 14, 2024 |
Related Tickers
BCTXW BriaCell Therapeutics Corp.
0.1706
+36.48%
LIXT Lixte Biotechnology Holdings, Inc.
1.2560
-4.12%
RNTX Rein Therapeutics Inc.
1.8300
+0.55%
IPHA Innate Pharma S.A.
2.0100
+2.03%
LTRN Lantern Pharma Inc.
3.6200
-2.95%
INTS Intensity Therapeutics, Inc.
0.9001
-30.76%
KAPA Kairos Pharma, Ltd.
0.8530
-0.81%
TRAW Traws Pharma, Inc.
1.5300
+4.08%
SPRB Spruce Biosciences, Inc.
0.1399
+5.27%
UBX Unity Biotechnology, Inc.
0.9837
-0.23%